Biotage AB (publ) (BITGF)
USD 11.5
(31.13%)
USD 11.5
(31.13%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 113.94 Million USD | 35.12% |
| 2022 | 84.32 Million USD | 7.12% |
| 2021 | 78.72 Million USD | 3.96% |
| 2020 | 75.72 Million USD | 10.14% |
| 2019 | 68.75 Million USD | 12.76% |
| 2018 | 60.97 Million USD | 16.63% |
| 2017 | 52.27 Million USD | 37.25% |
| 2016 | 38.08 Million USD | 3.63% |
| 2015 | 36.75 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 303 Million USD | 895.94% |
| 2024 Q2 | 30.42 Million USD | 7.5% |
| 2024 Q1 | 28.3 Million USD | -27.04% |
| 2023 Q1 | 21.09 Million USD | -2.68% |
| 2023 Q4 | 38.78 Million USD | 50.82% |
| 2023 FY | 99.98 Million USD | 18.57% |
| 2023 Q3 | 25.71 Million USD | 9.7% |
| 2023 Q2 | 23.44 Million USD | 11.12% |
| 2022 Q1 | 25.59 Million USD | 9.65% |
| 2022 Q4 | 21.67 Million USD | 0.28% |
| 2022 Q3 | 21.61 Million USD | -7.52% |
| 2022 FY | 84.32 Million USD | 7.12% |
| 2022 Q2 | 23.37 Million USD | -8.67% |
| 2021 Q4 | 23.34 Million USD | 12.08% |
| 2021 Q2 | 21.3 Million USD | 4.63% |
| 2021 FY | 78.72 Million USD | 3.96% |
| 2021 Q1 | 20.35 Million USD | 0.0% |
| 2021 Q3 | 20.82 Million USD | -2.24% |
| 2020 FY | 75.72 Million USD | 10.14% |
| 2019 FY | 68.75 Million USD | 12.76% |
| 2018 FY | 60.97 Million USD | 16.63% |
| 2017 FY | 52.27 Million USD | 37.25% |
| 2016 FY | 38.08 Million USD | 3.63% |
| 2015 FY | 36.75 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -6605.992% |
| Ansell Limited | 624.8 Million USD | 81.763% |
| Ansell Limited | 624.8 Million USD | 81.763% |
| BG Medicine, Inc. | - USD | -Infinity% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -84267.091% |
| Psykey, Inc. | 415.97 Thousand USD | -27291.478% |
| ConvaTec Group Plc | 1.2 Billion USD | 90.529% |
| ConvaTec Group Plc | 1.17 Billion USD | 90.301% |
| Encision Inc. | 3.13 Million USD | -3533.398% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -14250.14% |
| LifePoint, Inc. | -71.35 Thousand USD | 159776.525% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 87078.607% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -21603.233% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -18788.332% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -19004.286% |
| SmileDirectClub, Inc. | 275.84 Million USD | 58.694% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 87.35% |
| SheerVision, Inc. | 2.17 Million USD | -5136.523% |
| United Health Products, Inc. | -4857.00 USD | 2346033.189% |
| Vasamed, Inc. | -69.38 Thousand USD | 164309.914% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -42469.191% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -216305.787% |